BRG1 mutations found in human cancer cell lines inactivate Rb-mediated cell-cycle arrest

Journal of Cellular Physiology

Volumn 226, Issue 8, 2011, Pages 1989-1997

  Bartlett, Christopher ^a,c   Orvis, Tess J ^a   Rosson, Gary S ^a   Weissman, Bernard E ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c SciMetrika   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; BRG1 PROTEIN; HERMES ANTIGEN; MUTANT PROTEIN; RETINOBLASTOMA PROTEIN;

ARTICLE; CANCER CELL CULTURE; CELL CYCLE ARREST; CHROMATIN ASSEMBLY AND DISASSEMBLY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ADENOSINE TRIPHOSPHATASES; ANTIGENS, CD44; CADHERINS; CELL CYCLE; CELL LINE, TUMOR; CHROMOSOMAL PROTEINS, NON-HISTONE; DNA HELICASES; HUMANS; NUCLEAR PROTEINS; POINT MUTATION; PROMOTER REGIONS, GENETIC; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTORS;

EUKARYOTA;

EID: 79955090200     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22533     Document Type: Article

References (38)

1. Banine F, Bartlett C, Gunawardena R, Muchardt C, Yaniv M, Knudsen ES, Weissman BE, Sherman LS. 2005. SWI/SNF chromatin-remodeling factors induce changes in DNA methylation to promote transcriptional activation. Cancer Res 65: 3542-3547.
2. Barker N, Hurlstone A, Musisi H, Miles A, Bienz M, Clevers H. 2001. The chromatin remodelling factor Brg-1 interacts with beta-catenin to promote target gene activation. EMBO J 20: 4935-4943.
3. Betz BL, Strobeck MW, Reisman DN, Knudsen ES, Weissman BE. 2002. Re-expression of hSNF5/INI1/BAF47 in pediatric tumor cells leads to G1 arrest associated with induction of p16ink4a and activation of RB. Oncogene 21: 5193-5203.
4. Bultman S, Gebuhr T, Yee D, La Mantia C, Nicholson J, Gilliam A, Randazzo F, Metzger D, Chambon P, Crabtree G, Magnuson T. 2000. A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes. Mol Cell 6: 1287-1295.
5. Bultman SJ, Herschkowitz JI, Godfrey V, Gebuhr TC, Yaniv M, Perou CM, Magnuson T. 2008. Characterization of mammary tumors from Brg1 heterozygous mice. Oncogene 27: 460-468.
6. Chai J, Charboneau AL, Betz BL, Weissman BE. 2005. Loss of the hSNF5 gene concomitantly inactivates p21CIP/WAF1 and p16INK4a activity associated with replicative senescence in A204 rhabdoid tumor cells. Cancer Res 65: 10192-10198.
7. Clapier CR, Cairns BR. 2009. The biology of chromatin remodeling complexes. Annu Rev Biochem 78: 273-304.
8. Fukuoka J, Fujii T, Shih JH, Dracheva T, Meerzaman D, Player A, Hong K, Settnek S, Gupta A, Buetow K, Hewitt S, Travis WD, Jen J. 2004. Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer. Clin Cancer Res 10: 4314-4324.
9. Graff JR, Herman JG, Lapidus RG, Chopra H, Xu R, Jarrard DF, Isaacs WB, Pitha PM, Davidson NE, Baylin SB. 1995. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res 55: 5195-5199.
10. Hajra KM, Ji X, Fearon ER. 1999. Extinction of E-cadherin expression in breast cancer via a dominant repression pathway acting on proximal promoter elements. Oncogene 18: 7274-7279.
11. Hendricks KB, Shanahan F, Lees E. 2004. Role for BRG1 in cell cycle control and tumor suppression. Mol Cell Biol 24: 362-376.
12. Kadam S, Emerson BM. 2003. Transcriptional specificity of human SWI/SNF BRG1 and BRM chromatin remodeling complexes. Mol Cell 11: 377-389.
13. Kang H, Cui K, Zhao K. 2004. BRG1 controls the activity of the retinoblastoma protein via regulation of p21CIP1/WAF1/SDI. Mol Cell Biol 24: 1188-1199.
14. Kuwahara Y, Charboneau A, Knudsen ES, Weissman BE. 2010. Reexpression of hSNF5 in malignant rhabdoid tumor cell lines causes cell cycle arrest through a p21(CIP1/WAF1)-dependent mechanism. Cancer Res 70: 1854-1865.
15. Laurent BC, Treitel MA, Carlson M. 1991. Functional interdependence of the yeast SNF2, SNF5, and SNF6 proteins in transcriptional activation. Proc Natl Acad Sci 88: 2687-2691.
16. Lee D, Kim JW, Seo T, Hwang SG, Choi EJ, Choe J. 2002. SWI/SNF complex interacts with tumor suppressor p53 and is necessary for the activation of p53-mediated transcription. J Biol Chem 277: 22330-22337.
17. Link KA, Burd CJ, Williams E, Marshall T, Rosson G, Henry E, Weissman B, Knudsen KE. 2005. BAF57 governs androgen receptor action and androgen-dependent proliferation through SWI/SNF. Mol Cell Biol 25: 2200-2215.
18. Liu R, Liu H, Chen X, Kirby M, Brown PO, Zhao K. 2001. Regulation of CSF1 promoter by the SWI/SNF-like BAF complex. Cell 106: 309-318.
19. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25: 402-408.
20. Medina PP, Carretero J, Fraga MF, Esteller M, Sidransky D, Sanchez-Cespedes M. 2004. Genetic and epigenetic screening for gene alterations of the chromatin-remodeling factor, SMARCA4/BRG1, in lung tumors. Genes Chromosomes Cancer 41: 170-177.
21. Peterson CL, Herskowitz I. 1992. Characterization of the yeast SWI1, SWI2, and SWI3 genes, which encode a global activator of transcription. Cell 68: 573-583.
22. Reisman DN, Sciarrotta J, Wang W, Funkhouser WK, Weissman BE. 2003. Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: Correlation with poor prognosis. Cancer Res 63: 560-566.
23. Reisman DN, Strobeck MW, Betz BL, Sciariotta J, Funkhouser W, Jr., Murchardt C, Yaniv M, Sherman LS, Knudsen ES, Weissman BE. 2002. Concomitant down-regulation of BRM and BRG1 in human tumor cell lines: Differential effects on RB-mediated growth arrest vs CD44 expression. Oncogene 21: 1196-1207.
24. Reisman DN, Sciarrotta J, Bouldin TW, Weissman BE, Funkhouser WK. 2005. The expression of the SWI/SNF ATPase subunits BRG1 and BRM in normal human tissues. Appl Immunohistochem Mol Morphol 13: 66-74.
25. Reyes JC, Barra J, Muchardt C, Camus A, Babinet C, Yaniv M. 1998. Altered control of cellular proliferation in the absence of mammalian brahma (SNF2a). EMBO J 17: 6979-6991.
26. Rosson GB, Bartlett C, Reed W, Weissman BE. 2005. BRG1 loss in MiaPaCa2 cells induces an altered cellular morphology and disruption in the organization of the actin cytoskeleton. J Cell Physiol 205: 286-294.
27. Smith CL, Peterson CL. 2005. A conserved Swi2/Snf2 ATPase motif couples ATP hydrolysis to chromatin remodeling. Mol Cell Biol 25: 5880-5892.
28. Strobeck MW, Knudsen KE, Fribourg AF, DeCristofaro MF, Weissman BE, Imbalzano AN, Knudsen ES. 2000. BRG-1 is required for RB-mediated cell cycle arrest. Proc Natl Acad Sci USA 97: 7748-7753.
29. Strobeck MW, DeCristofaro MF, Banine F, Weissman BE, Sherman LS, Knudsen ES. 2001. The BRG-1 subunit of the SWI/SNF complex regulates CD44 expression. J Biol Chem 276: 9273-9278.
30. Strobeck MW, Reisman DN, Gunawardena RW, Betz BL, Angus SP, Knudsen KE, Kowalik TF, Weissman BE, Knudsen ES. 2002. Compensation of BRG-1 function by Brm: Insight into the role of the core SWI-SNF subunits in retinoblastoma tumor suppressor signaling. J Biol Chem 277: 4782-4789.
31. Versteege I, Sevenet N, Lange J, Rousseau-Merck MF, Ambros P, Handgretinger R, Aurias A, Delattre O. 1998. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 394: 203-206.
32. Wang GG, Allis CD, Chi P. 2007a. Chromatin remodeling and cancer, Part I: Covalent histone modifications. Trends Mol Med 13: 363-372.
33. Wang GG, Allis CD, Chi P. 2007b. Chromatin remodeling and cancer, Part II: ATP-dependent chromatin remodeling. Trends Mol Med 13: 373-380.
34. Wang W, Xue Y, Zhou S, Kuo A, Cairns BR, Crabtree GR. 1996. Diversity and specialization of mammalian SWI/SNF complexes. Genes Dev 10: 2117-2130.
35. Weissman B, Knudsen KE. 2009. Hijacking the chromatin remodeling machinery: Impact of SWI/SNF perturbations in cancer. Cancer Res 69: 8223-8230.
36. Wong AK, Shanahan F, Chen Y, Lian L, Ha P, Hendricks K, Ghaffari S, Iliev D, Penn B, Woodland AM, Smith R, Salada G, Carillo A, Laity K, Gupte J, Swedlund B, Tavtigian SV, Teng DH, Lees E. 2000. BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines. Cancer Res 60: 6171-6177.
37. Yamamichi-Nishina M, Ito T, Mizutani T, Yamamichi N, Watanabe H, Iba H. 2003. SW13 cells can transition between two distinct subtypes by switching expression of BRG1 and Brm genes at the post-transcriptional level. J Biol Chem 278: 7422-7430.
38. Zhang HS, Gavin M, Dahiya A, Postigo AA, Ma D, Luo RX, Harbour JW, Dean DC. 2000. Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF. Cell 101: 79-89.